New therapies are on the horizon for individuals paralyzed following spinal cord injury.
The e-Dura implant developed by EPFL scientists can be applied directly to the spinal cord without causing damage and inflammation. The device is described in an article appearing online January 8, 2015, in Science.
EPFL scientists have managed to get rats walking on their own again using a combination of electrical and chemical stimulation. But applying this method to humans would require multifunctional implants that could be installed for long periods of time on the spinal cord without causing any tissue damage. This is precisely what the teams of professors Stéphanie Lacour and Grégoire Courtine have developed. Their e-Dura implant is designed specifically for implantation on the surface of the brain or spinal cord. The small device closely imitates the mechanical properties of living tissue, and can simultaneously deliver electric impulses and pharmacological substances. The risks of rejection and/or damage to the spinal cord have been drastically reduced. An article about the implant will appear in early January in Science Magazine.
So-called “surface implants” have reached a roadblock; they cannot be applied long term to the spinal cord or brain, beneath the nervous system’s protective envelope, otherwise known as the “dura mater,” because when nerve tissues move or stretch, they rub against these rigid devices. After a while, this repeated friction causes inflammation, scar tissue buildup, and rejection.
An easy-does-it implant
Flexible and stretchy, the implant developed at EPFL is placed beneath the dura mater, directly onto the spinal cord. Its elasticity and its potential for deformation are almost identical to the living tissue surrounding it. This reduces friction and inflammation to a minimum. When implanted into rats, the e-Dura prototype caused neither damage nor rejection, even after two months. More rigid traditional implants would have caused significant nerve tissue damage during this period of time.
The researchers tested the device prototype by applying their rehabilitation protocol — which combines electrical and chemical stimulation – to paralyzed rats. Not only did the implant prove its biocompatibility, but it also did its job perfectly, allowing the rats to regain the ability to walk on their own again after a few weeks of training.
“Our e-Dura implant can remain for a long period of time on the spinal cord or the cortex, precisely because it has the same mechanical properties as the dura mater itself. This opens up new therapeutic possibilities for patients suffering from neurological trauma or disorders, particularly individuals who have become paralyzed following spinal cord injury,” explains Lacour, co-author of the paper, and holder of EPFL’s Bertarelli Chair in Neuroprosthetic Technology.
The Latest on: Neuroprosthetics
via Google News
The Latest on: Neuroprosthetics
- Babies Can Tell Who Has Close Relationships Based on One Clue: Salivaon January 20, 2022 at 9:56 pm
Kissing, sharing food, or any other interaction that involves saliva are signals babies and young children use to determine whether two people have a strong relationship and mutual obligation to each ...
- Neuroprosthetics Market 2022 : Global Trend, Share, Size Global Growth Analysis From 2022-2026 with Leading Regions and Countries Dataon January 19, 2022 at 5:12 am
Global “ Neuroprosthetics Market " is expected to grow at a steady growth during the forecast period 2021-2025, Neuroprosthetics Market report offers insights into the latest trends. It summarizes key ...
- Brain-Computer Interfaces: Separating Fact From Fiction On Musk’s Brain Implant Claimson January 17, 2022 at 4:00 pm
How much of this is just investor speak? Please join us as we take a look at BCIs, neuroprosthetics and what we can expect of these technologies in the coming years. The ATP-ADP cycle: ATP ...
- Technology Insight: Future Neuroprosthetic Therapies for Disorders of the Nervous Systemon January 11, 2022 at 4:00 pm
The emerging field of neuroprosthetics is focused on the development of therapeutic interventions that will be able to restore some of this lost neural function by selective electrical stimulation ...
- Neuroprosthetics Market Size is Projected To Reach USD 11450 Million By 2027 At A CAGR of 9.9% - Valuates Reportson January 7, 2022 at 6:23 am
BANGALORE, India, Jan. 7, 2022 /PRNewswire/ -- Neuroprosthetics Market By Type - Output Neuroprosthetics, Input Neuroprosthetics, By Application - Hospital, Clinic, Other. Global Opportunity ...
- Neuroprosthetics Market Size is Projected To Reach USD 11450 Million By 2027 At A CAGR of 9.9% - Valuates Reportson January 7, 2022 at 6:14 am
BANGALORE, India, Jan. 7, 2022 /PRNewswire/ -- Neuroprosthetics Market By Type - Output Neuroprosthetics, Input Neuroprosthetics, By Application - Hospital, Clinic ...
- Neuroprosthetics Market Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2026on January 6, 2022 at 5:28 am
Market Size – USD 6.1 Billion in 2018, Market Growth - CAGR of 12.4%, Market Trends – Product launches and research for advanced Neuroprosthetics NEW YORK, NY, UNITED STATES, January 5 ...
via Bing News